Team Science. No Borders. Bring It On.

Joined March 2021
103 Photos and videos
🚨🚨New paper alert 🚨🚨 nature.com/articles/s42255-0… rdcu.be/dVak3

1
8
15
1,719
We enable the community to query and visualise our results interactively through our webserver: omicscience.org/apps/protdet…
2
2
2
131
Huge thanks to @Julia_Czs @pietznerm @BurulcaU @KopruluMine @KastenmullerLab @Julian_H0ffmann and many others! @QMULBartsTheLon @MRC_Epid @berlinnovation
1
2
110
Want to get a summary of our paper and of the implications of our research? Check out our research briefing at @NatureMedicine nature.com/articles/s41591-0…

Precision medicine requires finding people at a high risk of disease. We used >3,000 proteins to develop sparse models for prediction of future risk of 218 diseases using #EHRs and #MachineLearning in @uk_biobank. nature.com/articles/s41591-0… rdcu.be/dOxQQ
2
2
279
Precision medicine requires finding people at a high risk of disease. We used >3,000 proteins to develop sparse models for prediction of future risk of 218 diseases using #EHRs and #MachineLearning in @uk_biobank. nature.com/articles/s41591-0… rdcu.be/dOxQQ
1
11
32
4,047
We make our results available through our webserver (omicscience.org/apps/protpre…) to visualise the potential benefit of #proteomic screening in a Bayesian framework.
1
115
Amazing industry-academia collaboration with @Julia_Czs @pietznerm @jonathandavitte @profhhemingway @robert_a_scott and many others @GSK @QMULBartsTheLon @UCL_IHI @MRC_epid @Cambridge_Uni
3
119
9 Jul 2024
Outstanding scientists elected to EMBO Membership: in EMBO’s 60th anniversary year, 100 new members and 20 associate members join the community embo.org/press-releases/outs…
1
1
272
We are so honoured for this recognition of our science. Go team!
9 Jul 2024
Outstanding scientists elected to EMBO Membership: in EMBO’s 60th anniversary year, 100 new members and 20 associate members join the community embo.org/press-releases/outs…
1
2
447
However, known risk loci for #COVID_19 seem to behave oddly, ie., not always agree in direction of effect on highly related disease. TYK2 challenges the popular genetically informed repurposing story of baricitinib (JAK-target); points to *adverse* effects of TYK2 inhibitors
1
89
Amazing collaboration with @SpirosDenaxas @pietznerm @_MatthiasArnold @KastenmullerLab @berlinnovation @QMULBartsTheLon @UCL_IHI
120